These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4236543)

  • 1. The value of fluorinated pyrimidines in advanced malignancy.
    Fennelly JJ; Fitzgerald MX
    Br J Cancer; 1968 Dec; 22(4):673-82. PubMed ID: 4236543
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phase II study of 5'-DFUR in gastrointestinal and breast cancer].
    Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2172-8. PubMed ID: 2933000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phase II study of 5'-DFUR (5'-deoxy-5-fluorouridine) by the Cooperative Study Group].
    Taguchi T; Sakai K; Terasawa T; Irie K; Okajima K; Yamamoto M; Kawahara T; Satomi T; Tomita K; Yamaguchi A
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2179-84. PubMed ID: 2933001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of 5'-deoxy-5-fluorouridine between older cancer patients versus younger cancer patients].
    Sumimura J; Morimoto Y; Miyazaki M; Ishikawa S; Nagai I
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):561-4. PubMed ID: 10097759
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenal function in patients treated with testosterone and fluorinated pyrimidines.
    Morrow LB; Burrow GN; Kaplan SR; Mulrow PJ
    J Clin Endocrinol Metab; 1968 Feb; 28(2):308-10. PubMed ID: 4295134
    [No Abstract]   [Full Text] [Related]  

  • 6. [Our experience with 5-fluoro-2-desocyuridine].
    Brulé G; Hane S
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):153-7. PubMed ID: 4232317
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical effect of 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Nakano Y; Ohota J; Fujita M; Taguchi T
    Gan No Rinsho; 1985 May; 31(6 Suppl):746-50. PubMed ID: 3162050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase II study of 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with malignant cancer--a multi-institutional cooperative study].
    Niitani H; Kimura K; Saito T; Nakao I; Abe O; Urushizaki I; Ohta K; Yoshida Y; Kimura T; Kurihara M
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2044-51. PubMed ID: 2932059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical modulation of fluoropyrimidines: is there an optimal (6R,S) leucovorin dose and schedule?
    Doroshow JH
    J Natl Cancer Inst; 1996 Apr; 88(7):393-5. PubMed ID: 8618231
    [No Abstract]   [Full Text] [Related]  

  • 10. Results of treatment of malignant tumors with ftorafur.
    Blokhina NG; Vozny EK; Garin AM
    Cancer; 1972 Aug; 30(2):390-2. PubMed ID: 5051663
    [No Abstract]   [Full Text] [Related]  

  • 11. [A study on pre-operative administration of 5'-DFUR in carcinomas of the gastric, breast, thyroid and colon].
    Munemoto Y; Omura K; Hikishima H; Okada Y; Hayashi H; Adachi I; Douden K; Watanabe Y; Iwa T
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2415-20. PubMed ID: 2148066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous intravenous infusions of 5-fluoro-2'-deoxyuridine in the treatment of solid tumors.
    DeConti RC; Kaplan SR; Papac RJ; Calabresi P
    Cancer; 1973 Apr; 31(4):894-8. PubMed ID: 4267531
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical trial of 5'-deoxy-5-fluorouridine in malignant tumors under cooperative study (phase II study)].
    Murakami M; Ota K; Yasue M; Hoshino A; Kamiya O; Kinoshita T; Yamada M; Hiraiwa K; Hachisuka K; Yamaguchi A
    Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):1026-35. PubMed ID: 2944975
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy of residual disease in solid tumours.
    Kenis Y
    Rev Eur Etud Clin Biol; 1971 Feb; 16(2):103-7. PubMed ID: 4324078
    [No Abstract]   [Full Text] [Related]  

  • 15. [Phase II study of FF-705 by Clinical Cooperative Study Group].
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):150-6. PubMed ID: 6230055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined 5-fluorouracil and vinblastine therapy for gastrointestinal and other solid tumors.
    al-Sarraf M; Vaughn CB; Reed ML; Vaitkevicious VK
    Oncology; 1972; 26(2):99-113. PubMed ID: 5049925
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical phase II study of 5'-DFUR for cancer of the digestive organs by a cooperative study group].
    Urushizaki I; Kogo Y; Kouda K; Ishitani K; Niitsu Y; Matsuda M; Gocho Y; Koyama R; Nagai T; Saijo N
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2358-64. PubMed ID: 3000300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic artery infusion of 5-FUDR after prior systemic 5-fluorouracil.
    Buroker T; Samson M; Correa J; Fraile R; Vaitkevicius VK
    Cancer Treat Rep; 1976 Sep; 60(9):1277-9. PubMed ID: 138480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenocarcinomas of stomach, pancreas, liver, and biliary tracts. Survival of 328 patients treated with fluoropyrimidine therapy.
    Davis HL; Ramirez G; Ansfield FJ
    Cancer; 1974 Jan; 33(1):193-7. PubMed ID: 4272473
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fluorinated pyrimidines administered by percutaneous arterial perfusion in primary or secondary cancers of the liver].
    Ryan R; Metman EH; Oberfield R; Glouse M
    Bull Cancer; 1977; 64(3):409-20. PubMed ID: 200295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.